ResMed Inc. logo
RMDResMed Inc.

EV/EBITDA Ratio: 12.99x

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 12.99x is 46% below its 5-year average of 24.01x, near the low end of its 5-year range (11.92x–39.82x).

As of Friday, June 26, 2026. 28.50% below its 12-month average of 18.17x.

RMD EV/EBITDA Ratio

RMD EV/EBITDA Ratio Chart

12.99x
-39.86% 1Y
RMD EV/EBITDA Ratio

RMD Average EV/EBITDA Ratio Chart

RMD EV/EBITDA Ratio

RMD Current vs Average EV/EBITDA Ratio Chart

RMD EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

12.99x

EV/EBITDA RATIO AVG TTM

18.17x

EV/EBITDA RATIO AVG 3Y

20.02x

EV/EBITDA RATIO AVG 5Y

24.01x

EV/EBITDA RATIO AVG 10Y

24.18x

EV/EBITDA RATIO AVG 15Y

21.56x

EV/EBITDA RATIO AVG 20Y

20.64x

CURRENT VS TTM AVG

-28.50%

CURRENT VS 3Y AVG

-35.12%

CURRENT VS 5Y AVG

-45.89%

CURRENT VS 10Y AVG

-46.27%

CURRENT VS 15Y AVG

-39.74%

CURRENT VS 20Y AVG

-37.05%

RMD Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
ResMed Inc. (RMD)$28.81B12.99x18.17x20.02x24.01x
Biogen Inc. (BIIB)vs ›$29.82B12.27x8.87x11.18x12.21x
IQVIA Holdings Inc. (IQV)vs ›$31.12B13.01x13.63x15.05x17.06x
DexCom, Inc. (DXCM)vs ›$26.49B18.49x24.78x41.66x69.99x
Veeva Systems Inc. (VEEV)vs ›$25.68B18.81x32.42x43.46x53.37x
Medline Inc. (MDLN)vs ›$31.94B15.22x16.10x16.10x16.10x
Centene Corp. (CNC)vs ›$31.98BN/A4.99x7.28x9.49x
Mettler-Toledo International Inc. (MTD)vs ›$25.13B21.87x23.50x23.82x26.37x
Zoetis Inc. (ZTS)vs ›$32.62B9.97x15.30x20.50x23.58x
Waters Corporation (WAT)vs ›$24.57B39.01x22.27x21.51x21.55x

EV/EBITDA vs. its own history

At 13.0, EV/EBITDA is cheaper than usual, sitting higher than 4% of its 20-year history.

20-year low

10.1

median

19.7

20-year high

39.8

cheaperricher

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for ResMed Inc. (RMD)?
The EV/EBITDA ratio for RMD stock is 12.99x.
Is ResMed Inc.'s EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 12.99x is 46% below its 5-year average of 24.01x, near the low end of its 5-year range (11.92x–39.82x).
What is the TTM average EV/EBITDA ratio for ResMed Inc. (RMD)?
The TTM average EV/EBITDA ratio for RMD stock is 18.17x.
What is the 3Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
The 3Y average EV/EBITDA ratio for RMD stock is 20.02x.
What is the 5Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
The 5Y average EV/EBITDA ratio for RMD stock is 24.01x.
What is the 10Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
The 10Y average EV/EBITDA ratio for RMD stock is 24.18x.
What is the 15Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
The 15Y average EV/EBITDA ratio for RMD stock is 21.56x.
What is the 20Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
The 20Y average EV/EBITDA ratio for RMD stock is 20.64x.

RMD EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-06-2512.99x
2026-06-2412.85x
2026-06-2312.49x
2026-06-2212.30x
2026-06-1812.32x
2026-06-1712.16x
2026-06-1612.67x
2026-06-1512.59x
2026-06-1212.73x
2026-06-1112.57x
2026-06-1012.65x
2026-06-0912.87x
2026-06-0812.62x
2026-06-0512.81x
2026-06-0412.70x
2026-06-0312.17x
2026-06-0211.92x
2026-06-0112.17x
2026-05-2912.45x
2026-05-2813.31x
2026-05-2713.49x
2026-05-2613.62x
2026-05-2213.62x
2026-05-2113.68x
2026-05-2013.74x
2026-05-1913.60x
2026-05-1813.36x
2026-05-1513.21x
2026-05-1413.25x
2026-05-1313.24x
2026-05-1213.34x
2026-05-1113.00x
2026-05-0813.54x
2026-05-0713.54x
2026-05-0613.73x
2026-05-0513.61x
2026-05-0413.71x
2026-05-0113.42x
2026-04-3014.01x
2026-04-2914.84x
2026-04-2815.21x
2026-04-2715.56x
2026-04-2415.40x
2026-04-2315.38x
2026-04-2215.56x
2026-04-2115.50x
2026-04-2015.85x
2026-04-1715.99x
2026-04-1615.75x
2026-04-1516.04x
2026-04-1416.17x
2026-04-1316.14x
2026-04-1016.04x
2026-04-0915.98x
2026-04-0816.17x
2026-04-0715.84x
2026-04-0615.76x
2026-04-0215.70x
2026-04-0115.62x
2026-03-3115.73x
2026-03-3015.42x
2026-03-2715.45x
2026-03-2615.59x
2026-03-2515.86x
2026-03-2416.00x
2026-03-2315.98x
2026-03-2015.84x
2026-03-1915.94x
2026-03-1815.97x
2026-03-1716.37x
2026-03-1616.17x
2026-03-1316.18x
2026-03-1216.30x
2026-03-1116.84x
2026-03-1017.34x
2026-03-0917.75x
2026-03-0617.75x
2026-03-0517.92x
2026-03-0418.19x
2026-03-0318.13x
2026-03-0218.07x
2026-02-2717.99x
2026-02-2618.04x
2026-02-2517.72x
2026-02-2417.66x
2026-02-2318.31x
2026-02-2018.19x
2026-02-1917.99x
2026-02-1818.18x
2026-02-1717.96x
2026-02-1317.72x
2026-02-1217.24x
2026-02-1118.23x
2026-02-1018.50x
2026-02-0919.39x
2026-02-0619.08x
2026-02-0518.75x
2026-02-0418.47x
2026-02-0317.64x
2026-02-0217.88x
2026-01-3018.13x
2026-01-2918.08x
2026-01-2818.83x
2026-01-2718.66x
2026-01-2618.66x
2026-01-2318.43x
2026-01-2218.65x
2026-01-2118.94x
2026-01-2018.49x
2026-01-1618.82x
2026-01-1519.05x
2026-01-1418.96x
2026-01-1318.60x
2026-01-1218.84x
2026-01-0918.44x
2026-01-0818.32x
2026-01-0718.12x
2026-01-0618.19x
2026-01-0517.91x
2026-01-0217.87x
2025-12-3117.58x
2025-12-3017.74x
2025-12-2917.72x
2025-12-2617.87x
2025-12-2417.84x
2025-12-2317.85x
2025-12-2218.01x
2025-12-1917.88x
2025-12-1817.70x
2025-12-1717.95x
2025-12-1618.06x
2025-12-1518.48x
2025-12-1218.42x
2025-12-1118.43x
2025-12-1018.37x
2025-12-0918.00x
2025-12-0818.26x
2025-12-0518.74x
2025-12-0418.37x
2025-12-0318.36x
2025-12-0218.32x
2025-12-0118.13x
2025-11-2818.69x
2025-11-2618.63x
2025-11-2518.68x
2025-11-2418.29x
2025-11-2118.31x
2025-11-2017.80x
2025-11-1917.88x
2025-11-1817.97x
2025-11-1717.86x
2025-11-1417.84x
2025-11-1318.41x
2025-11-1218.47x
2025-11-1118.43x
2025-11-1018.26x
2025-11-0718.37x
2025-11-0618.23x
2025-11-0517.90x
2025-11-0417.99x
2025-11-0318.18x
2025-10-3118.02x
2025-10-3018.42x
2025-10-2919.20x
2025-10-2819.43x
2025-10-2719.63x
2025-10-2419.65x
2025-10-2320.09x
2025-10-2220.18x
2025-10-2120.32x
2025-10-2020.56x
2025-10-1720.31x
2025-10-1620.45x
2025-10-1520.43x
2025-10-1420.46x
2025-10-1320.68x
2025-10-1020.60x
2025-10-0921.05x
2025-10-0821.40x
2025-10-0721.47x
2025-10-0621.32x
2025-10-0321.11x
2025-10-0220.96x
2025-10-0120.52x
2025-09-3020.74x
2025-09-2920.53x
2025-09-2620.47x
2025-09-2520.25x
2025-09-2420.77x
2025-09-2320.88x
2025-09-2220.79x
2025-09-1920.70x
2025-09-1820.70x
2025-09-1720.58x
2025-09-1620.65x
2025-09-1520.54x
2025-09-1220.46x
2025-09-1120.80x
2025-09-1020.49x
2025-09-0921.15x
2025-09-0821.17x
2025-09-0520.99x
2025-09-0420.74x
2025-09-0320.39x
2025-09-0220.53x
2025-08-2920.80x
2025-08-2820.86x
2025-08-2721.37x
2025-08-2621.61x
2025-08-2521.66x
2025-08-2222.27x
2025-08-2121.85x
2025-08-2021.91x
2025-08-1921.68x
2025-08-1821.68x
2025-08-1521.59x
2025-08-1421.58x
2025-08-1321.85x
2025-08-1221.47x
2025-08-1121.55x
2025-08-0821.51x
2025-08-0721.23x
2025-08-0623.49x
2025-08-0523.87x
2025-08-0424.41x
2025-08-0123.39x
2025-07-3122.78x
2025-07-3023.24x
2025-07-2923.26x
2025-07-2822.91x
2025-07-2523.05x
2025-07-2422.91x
2025-07-2322.90x
2025-07-2222.40x
2025-07-2121.86x
2025-07-1821.60x
2025-07-1721.47x
2025-07-1621.29x
2025-07-1521.10x
2025-07-1421.28x
2025-07-1121.30x
2025-07-1021.61x
2025-07-0921.44x
2025-07-0821.49x
2025-07-0721.47x
2025-07-0321.52x
2025-07-0221.43x
2025-07-0121.46x
2025-06-3021.61x
2025-06-2721.37x
2025-06-2621.46x
2025-06-2521.60x
2025-06-2421.43x
2025-06-2321.31x
2025-06-2021.24x
2025-06-1821.01x
2025-06-1720.94x
2025-06-1621.08x
2025-06-1320.88x
2025-06-1221.12x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

San Diego, CA
9,980 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael J. Farrell